Healthcare research in Montgomery County, page 156
A filtered view. Show the full list.
Refine
Listings
-
Clinical trial reportBlood
Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 study
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleBlood
Ramantamig (JNJ-79635322), a novel T-cell-engaging trispecific antibody targeting BCMA, GPRC5D, and CD3, in multiple myeloma models
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Disease researchAdded
-
Clinical trial reportBlood
Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Disease researchAdded
-
ArticleBlood advances
Real-world survival outcomes in first-line ibrutinib-treated patients with high-risk CLL/SLL
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportBlood advances
Infections and parameters of humoral immunity with talquetamab in relapsed/refractory multiple myeloma in MonumenTAL-1
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleBlood advances
Long-term remission after cilta-cel in multiple myeloma is linked to diverse T cells and low myeloid suppression
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Disease researchAdded
-
LetterERJ open research
Effects of seasonality and treatment on COPD clinical outcomes: IMPACT post hoc analysis
Verified Author affiliations on the Europe PMC record name GSK, Lewis Katz School of Medicine, Perelman School of Medicine, Temple University, University of Pennsylvania. Affiliation source
Clinical careAdded
-
EditorialERJ open research
ERS Congress 2024: highlights from the Thoracic Oncology Assembly
Verified An author affiliation on the Europe PMC record names Lankenau Institute for Medical Research, with Main Line Health linked by the institution reference. Affiliation source
Disease researchAdded
-
ArticleBMC cardiovascular disorders
Exploring sex-specific clinical features in Chinese patients with Takotsubo syndrome
Verified Author affiliations on the Europe PMC record name Lankenau Institute for Medical Research, Sidney Kimmel Medical College, Thomas Jefferson University, with Main Line Health linked by the institution reference. Affiliation source
Disease researchAdded
-
ReviewBMC cardiovascular disorders
Cusp-overlap view versus three cusp coplanar view during transcatheter aortic valve replacement using self-expandable valves: a systematic review, meta-analysis and meta-regression
Verified An author affiliation on the Europe PMC record names Lankenau Institute for Medical Research, with Main Line Health linked by the institution reference. Affiliation source
Clinical careAdded
-
ArticleBMC infectious diseases
A qualitative burden of disease study in patients with invasive Escherichia coli disease aged ≥ 60 years in the United States
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Disease researchAdded
-
ReviewPopulation health metrics
Evaluation and forecasting methods to estimate number of patients with non-Hodgkin lymphoma: a systematic literature review
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
Public healthAdded
-
ArticleSubstance abuse treatment, prevention, and policy
Initial stakeholder perceptions around opioid settlement funds in Pennsylvania
Verified An author affiliation on the Europe PMC record names Pennsylvania State University. Affiliation source
Public healthAdded
-
ArticleTrials
Guselkumab versus golimumab in patients with active psoriatic arthritis and inadequate response to an initial tumor necrosis factor inhibitor: study protocol for EVOLUTION, a pragmatic, phase 3b, open-label, randomized, controlled effectiveness trial
Verified Author affiliations on the Europe PMC record name Drexel University College of Medicine, Johnson & Johnson, Perelman School of Medicine, with Drexel University, University of Pennsylvania linked by the institution reference. Affiliation source
Clinical careAdded
-
ArticlePilot and feasibility studies
Culinary medicine for caregivers: protocol for a mixed-methods feasibility study to improve pediatric cancer patient and caregiver outcomes through nutrition and culinary support
Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Drexel University, Perelman School of Medicine, University of Pennsylvania. Affiliation source
Clinical careAdded
-
ArticleJournal of patient-reported outcomes
Content validity and meaningful change for the FACIT-Fatigue scale in warm autoimmune hemolytic anemia: results from qualitative interview studies with patients
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Research dataAdded
-
ReviewJournal of clinical oncology : official journal of the American Society of Clinical Oncology
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update
Verified An author affiliation on the Europe PMC record names Jefferson Health. Affiliation source
Clinical careAdded
-
ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology
Amivantamab Plus Lazertinib in Atypical EGFR-Mutated Advanced Non-Small Cell Lung Cancer: Results From CHRYSALIS-2
Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania. Affiliation source
Disease researchAdded
-
Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical Oncology
Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology
Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma
Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania. Affiliation source
Clinical careAdded
-
Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical Oncology
TAR-200 for Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology
Gemcitabine Intravesical System Plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer: SunRISe-4 Primary Analysis and Biomarker Results
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Disease researchAdded
-
ArticleJCO oncology practice
Prostate Cancer Foundation White Paper on Combination Therapy for Metastatic Hormone-Sensitive Prostate Cancer
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleThe AAPS journal
Blend Uniformity and Content Uniformity in Oral Solid Dosage Manufacturing: an IQ Consortium Industry Position Paper
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source